Are reduced tacrolimus dosages needed in the early postoperative period following living donor liver transplantation in adults?

Transplantation Proceedings

Volumn 34, Issue 5, 2002, Pages 1531-1532

  Troisi, R ^a,c   Militerno, G ^a   Hoste, E ^b   Decruyenaere, J ^b   Colpaert, K ^b   Monsieurs, K ^b   Colle, I ^c   Van Vlierberghe, H ^c   De Hemptinne, B ^a  

^a Department of Hepato Biliary and Liver Transplantation Surgery ^*  (Belgium)

^b Intensive Care Unit   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SAFETY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; ARTICLE; BODY WEIGHT; IMMUNOLOGY; LIVING DONOR; ORGAN SIZE; PHYSIOLOGY; POSTOPERATIVE PERIOD;

ADULT; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; ORGAN WEIGHT; POSTOPERATIVE PERIOD; TACROLIMUS; HUMANS; ORGAN SIZE;

EID: 0035993623     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)03007-5     Document Type: Conference Paper

References (5)